← Leaderboards
Nicole K Paulk
Oregon Health & Science University
$1,083,618
Attributed
$1,083,618
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $165.2K · FY2007–20$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,083,618 · 3
By mechanism
K01$782,093 · 1
F31$182,417 · 1
F32$119,108 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Branden D Tarlow$219,204
- Jevgenia Zilberman-Rudenko$161,420
- Amita Tiyaboonchai$187,710
- Hiroyuki Nakai$9,286,279
- Anne Vonada$664,769
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesHepatocyteLiverMetabolicIn VivoUnited States National Institutes Of HealthAffectLiver DiseasesTherapeutic GeneCellsMethodologyPre-ClinicalPropertySerotypingPreventCapsidAnimal ModelLibrariesGene TherapyEventClinical TrialsDependovirusIn VitroTrafficking
Grant awards (13)
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases$157,569
K01 · FY2020 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases$157,569
K01 · FY2019 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases$157,569
K01 · FY2018 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases.$153,943
K01 · FY2017 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases.$155,443
K01 · FY2016 · DK · contact PI
Novel strategies to expand the adeno-associated virus platform.$9,784
F32 · FY2016 · HL · contact PI
Novel strategies to expand the adeno-associated virus platform.$56,042
F32 · FY2015 · HL · contact PI
Novel strategies to expand the adeno-associated virus platform.$53,282
F32 · FY2014 · HL · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$33,262
F31 · FY2011 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$41,380
F31 · FY2010 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$40,300
F31 · FY2009 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$38,721
F31 · FY2008 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$28,754
F31 · FY2007 · CA · contact PI